Abbott Diabetes Care Inc.
Operating companyCorporate group: Abbott Group · HQ: United States
Not counted above: 3 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View
Abbott Diabetes Care Inc. has been party to 62 Unified Patent Court cases, 41 times as claimant and 21 times as respondent. The most recent on record is UPC CFI 3601/2026 at the Milan Local Division, against Shenzhen SiSensing Co., Ltd. Its most recent decision on the merits was in UPC CoA 884/2025 on 14 August 2026: patent upheld as granted.
- 2026-10-08UPC CFI 3601/2026Milan LD—Abbott Diabetes Care Inc. v Shenzhen SiSensing Co., Ltd
- 2026-09-22UPC CoA 162/2026Court of Appeal—Shenzhen SiSensing Co., Ltd v Abbott Diabetes Care Inc.
- 2026-08-07UPC CFI 2852/2026Hamburg LD—Malikie Innovations Ltd. v Abbott Laboratories
- 2026-05-18UPC CFI 1743/2026The Hague LD—Abbott Diabetes Care Inc. v Sinocare Inc.
- 2026-03-27UPC CFI 1086/2026Milan LDPI grantedAbbott Diabetes Care Inc. v Shenzhen SiSensing Co., Ltd
- 2026-03-16UPC CFI 943/2026The Hague LD—Sinocare Inc. v Abbott Diabetes Care Inc.
- 2026-03-09UPC CFI 865/2026The Hague LD—Abbott Diabetes Care Inc. v MicroTech Medical (Hangzhou) Co., Ltd.
- 2026-03-09UPC CFI 866/2026The Hague LD—Abbott Diabetes Care Inc. v MicroTech Medical (Hangzhou) Co., Ltd.
- 2025-11-17UPC CFI 1613/2025The Hague LDProcedural onlyAbbott Diabetes Care Inc. v Sinocare Inc.
- 2025-11-06UPC CoA 901/2025Court of AppealPI grantedAbbott Diabetes Care Inc. v A. Menarini Diagnostics s.r.l.